July 23, 2014

The Food and Drug Administration on Wednesday announced approval for Zydelig (idelalisib) to treat patients with chronic lymphocytic leukemia, relapsed follicular B-cell non-Hodgkin lymphoma and relapsed small lymphocytic lymphoma.

February 13, 2014

Janssen Biotech announced that the Food and Drug Administration has approved Imbruvica (ibrutinib) capsules for the treatment of patients with chronic lymphocytic leukemia who have received at least one prior therapy.

July 22, 2013

The philanthropic division of supermarket chain Stater Bros. has raised more than a quarter-million dollars for blood cancers.

April 26, 2013

More than 200 drugs for blood cancers are under development, according to a new report by a drug industry trade group.

October 9, 2012

A drug maker and a hospital have entered an agreement aimed at developing new treatments for various types of hematological malignancies and solid tumors.

July 23, 2012

The Food and Drug Administration has approved a new drug for treating multiple myeloma, the agency said Friday.

March 6, 2012

Takeda Pharmaceutical's cancer drug unit has started a late-stage clinical trial of a drug for treating a rare form of lymphoma, the company said.

October 27, 2010

The Food and Drug Administration has approved a new usage for a blood cancer drug,...

June 29, 2010

A biotechnology company will be acquired by one of the world's largest drug makers....

June 17, 2010

The Food and Drug Administration has approved a drug as an early treatment for a...

June 15, 2010

Stater Bros. is partnering with The Leukemia & Lymphoma Society for three weeks in June...